APA aipamena

Tan, D. H. S., Rolon, M. J., Figueroa, M. I., Sued, O., Gun, A., Kaul, R., . . . Cahn, P. (2019). Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: Substudy of a randomized trial. PLoS One.

Chicago Style aipamena

Tan, Darrell H. S., et al. "Inflammatory Biomarker Levels Over 48 Weeks With Dual Vs Triple Lopinavir/ritonavir-based Therapy: Substudy of a Randomized Trial." PLoS One 2019.

MLA aipamena

Tan, Darrell H. S., et al. "Inflammatory Biomarker Levels Over 48 Weeks With Dual Vs Triple Lopinavir/ritonavir-based Therapy: Substudy of a Randomized Trial." PLoS One 2019.